{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T17:40:45Z","timestamp":1790185245806,"version":"4.1.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,9]],"date-time":"2025-02-09T00:00:00Z","timestamp":1739059200000},"content-version":"am","delay-in-days":284,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["1T32GM144873-01"],"award-info":[{"award-number":["1T32GM144873-01"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000241","name":"PSI Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000241","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AG057598"],"award-info":[{"award-number":["AG057598"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010523","name":"Centre for Addiction and Mental Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010523","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000064","name":"University of Toronto Banting and Best Diabetes Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000064","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["MH121102"],"award-info":[{"award-number":["MH121102"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["MH107487"],"award-info":[{"award-number":["MH107487"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003579","name":"University of Toronto","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003579","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015070","name":"Department of Psychiatry, University of Toronto","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015070","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014405","name":"Centre for Addiction and Mental Health Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014405","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychoneuroendocrinology"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.psyneuen.2024.106987","type":"journal-article","created":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T13:07:06Z","timestamp":1707224826000},"page":"106987","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Olanzapine\u2019s effects on hypothalamic transcriptomics and kinase activity"],"prefix":"10.1016","volume":"163","author":[{"given":"Sandra","family":"Pereira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura N.","family":"Castellani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantel","family":"Kowalchuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaled","family":"Alganem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William G.","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raghunath","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Au","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roshanak","family":"Asgariroozbehani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sri Mahavir","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adria","family":"Giacca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert E.","family":"Mccullumsmith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret K.","family":"Hahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.psyneuen.2024.106987_bib1","doi-asserted-by":"crossref","first-page":"862","DOI":"10.2337\/diabetes.54.3.862","article-title":"Metabolic dysregulation with atypical antipsychotics occurs in the absence of underlying disease: a placebo-controlled study of olanzapine and risperidone in dogs","volume":"54","author":"Ader","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.psyneuen.2024.106987_bib2","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3389\/fendo.2020.00195","article-title":"Immunoendocrine peripheral effects induced by atypical antipsychotics","volume":"11","author":"Alvarez-Herrera","year":"2020","journal-title":"Front Endocrinol."},{"key":"10.1016\/j.psyneuen.2024.106987_bib3","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/s41380-018-0044-2","article-title":"Pharmacological treatment of adult bipolar disorder","volume":"24","author":"Baldessarini","year":"2019","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2024.106987_bib4","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1177\/0269881118754708","article-title":"Pathophysiology of drug induced weight and metabolic effects: findings from an RCT in healthy volunteers treated with olanzapine, iloperidone, or placebo","volume":"32","author":"Ballon","year":"2018","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.psyneuen.2024.106987_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104589","article-title":"Exploring mechanisms of increased cardiovascular disease risk with antipsychotic medications: risperidone alters the cardiac proteomic signature in mice","volume":"152","author":"Beauchemin","year":"2020","journal-title":"Pharm. Res."},{"key":"10.1016\/j.psyneuen.2024.106987_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0069668","article-title":"Modulation of the Akt pathway reveals a novel link with PERK\/eIF2\u03b1, which is relevant during hypoxia","volume":"8","author":"Blaustein","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.psyneuen.2024.106987_bib7","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/978-3-642-25761-2_3","article-title":"Dopamine receptor signaling and current and future antipsychotic drugs","author":"Boyd","year":"2012","journal-title":"Handb. Exp. Pharm."},{"key":"10.1016\/j.psyneuen.2024.106987_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0053459","article-title":"Metabolic side-effects of the novel second-generation antipsychotic drugs asenapine and iloperidone: a comparison with olanzapine","volume":"8","author":"Boyda","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.psyneuen.2024.106987_bib9","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1210\/endrev\/bnac033","article-title":"New insights into the structure and function of class B1 GPCRs","volume":"44","author":"Cary","year":"2023","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.psyneuen.2024.106987_bib10","doi-asserted-by":"crossref","first-page":"4741","DOI":"10.1038\/s41380-022-01798-y","article-title":"Antipsychotics impair regulation of glucose metabolism by central glucose","volume":"27","author":"Castellani","year":"2022","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2024.106987_bib11","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1097\/JCP.0b013e318184b4c5","article-title":"Insulin resistance and decreased glucose-stimulated insulin secretion after acute olanzapine administration","volume":"28","author":"Chintoh","year":"2008","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.psyneuen.2024.106987_bib12","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.schres.2008.12.012","article-title":"Insulin resistance and secretion in vivo: effects of different antipsychotics in an animal model","volume":"108","author":"Chintoh","year":"2009","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psyneuen.2024.106987_bib13","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/1471-244X-9-57","article-title":"Effects of typical and atypical antipsychotic drugs on gene expression profiles in the liver of schizophrenia subjects","volume":"9","author":"Choi","year":"2009","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.psyneuen.2024.106987_bib14","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1182\/blood-2006-11-053728","article-title":"Heat shock protein inhibition is associated with activation of the unfolded protein response pathway in myeloma plasma cells","volume":"110","author":"Davenport","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.psyneuen.2024.106987_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.663102","article-title":"Immunomodulatory effects of dopamine in inflammatory diseases","volume":"12","author":"Feng","year":"2021","journal-title":"Front Immunol."},{"key":"10.1016\/j.psyneuen.2024.106987_bib16","article-title":"Adipose tissue as a target for second-generation (atypical) antipsychotics: a molecular view","volume":"1865","author":"Ferreira","year":"2020","journal-title":"Biochim Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.psyneuen.2024.106987_bib17","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-50708-w","article-title":"Anti-inflammatory and antioxidant effects of muscarinic acetylcholine receptor (mAChR) activation in the rat hippocampus","volume":"9","author":"Frinchi","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.psyneuen.2024.106987_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.jprot.2020.103813","article-title":"Blood plasma proteomic modulation induced by olanzapine and risperidone in schizophrenia patients","volume":"224","author":"Garcia-Rosa","year":"2020","journal-title":"J. Proteom."},{"key":"10.1016\/j.psyneuen.2024.106987_bib19","doi-asserted-by":"crossref","first-page":"5016","DOI":"10.1158\/1078-0432.CCR-12-3510","article-title":"A purine scaffold HSP90 inhibitor BIIB021 has selective activity against KSHV-associated primary effusion lymphoma and blocks vFLIP K13-induced NF-\u03baB","volume":"19","author":"Gopalakrishnan","year":"2013","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.psyneuen.2024.106987_bib20","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.psyneuen.2019.03.017","article-title":"Olanzapine-induced endoplasmic reticulum stress and inflammation in the hypothalamus were inhibited by an ER stress inhibitor 4-phenylbutyrate","volume":"104","author":"He","year":"2019","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psyneuen.2024.106987_bib21","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1124\/mol.108.050070","article-title":"Endoplasmic reticulum stress induces leptin resistance","volume":"74","author":"Hosoi","year":"2008","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.psyneuen.2024.106987_bib22","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/sj.npp.1301209","article-title":"Acute effects of atypical antipsychotics on whole-body insulin resistance in rats: implications for adverse metabolic effects","volume":"32","author":"Houseknecht","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.psyneuen.2024.106987_bib23","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/S0022-3565(24)39105-0","article-title":"Radicicol suppresses expression of inducible nitric-oxide synthase by blocking p38 kinase and nuclear factor-kappaB\/Rel in lipopolysaccharide-stimulated macrophages","volume":"294","author":"Jeon","year":"2000","journal-title":"J. Pharm. Exp. Ther."},{"key":"10.1016\/j.psyneuen.2024.106987_bib24","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0304-3940(99)00610-2","article-title":"Differential effects of treatment with typical and atypical antipsychotic drugs on adenylyl cyclase and G proteins","volume":"273","author":"Kaplan","year":"1999","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.psyneuen.2024.106987_bib25","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1124\/jpet.102.046987","article-title":"Antipsychotic dosing in preclinical models is often unrepresentative of the clinical condition: a suggested solution based on in vivo occupancy","volume":"305","author":"Kapur","year":"2003","journal-title":"J. Pharm. Exp. Ther."},{"key":"10.1016\/j.psyneuen.2024.106987_bib26","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.2337\/db10-0308","article-title":"Tauroursodeoxycholic acid may improve liver and muscle but not adipose tissue insulin sensitivity in obese men and women","volume":"59","author":"Kars","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.psyneuen.2024.106987_bib27","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1503\/jpn.170092","article-title":"In male rats, the ability of central insulin to suppress glucose production is impaired by olanzapine, whereas glucose uptake is left intact","volume":"42","author":"Kowalchuk","year":"2017","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.psyneuen.2024.106987_bib28","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1152\/ajpendo.00164.2018","article-title":"Antipsychotics and glucose metabolism: how brain and body collide","volume":"316","author":"Kowalchuk","year":"2019","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.psyneuen.2024.106987_bib29","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.1172\/JCI93362","article-title":"The atypical antipsychotic olanzapine causes weight gain by targeting serotonin receptor 2C","volume":"127","author":"Lord","year":"2017","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.psyneuen.2024.106987_bib30","doi-asserted-by":"crossref","first-page":"E1101","DOI":"10.1152\/ajpendo.00309.2020","article-title":"GLP1 receptor agonism protects against acute olanzapine-induced hyperglycemia","volume":"319","author":"Medak","year":"2020","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.psyneuen.2024.106987_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2019.106093","article-title":"Treatment with the antipsychotic risperidone is associated with increased M1-like JAK-STAT1 signature gene expression in PBMCs from participants with psychosis and THP-1 monocytes and macrophages","volume":"79","author":"Melbourne","year":"2020","journal-title":"Int Immunopharmacol."},{"issue":"1","key":"10.1016\/j.psyneuen.2024.106987_bib32","doi-asserted-by":"crossref","DOI":"10.1186\/1868-7083-6-1","article-title":"The effects of olanzapine on genome-wide DNA methylation in the hippocampus and cerebellum","volume":"6","author":"Melka","year":"2014","journal-title":"Clin. Epigenetics"},{"key":"10.1016\/j.psyneuen.2024.106987_bib33","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.tips.2008.06.007","article-title":"Signaling at G-protein-coupled serotonin receptors: recent advances and future research directions","volume":"29","author":"Millan","year":"2008","journal-title":"Trends Pharm. Sci."},{"key":"10.1016\/j.psyneuen.2024.106987_bib34","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ejphar.2008.01.019","article-title":"Olanzapine inhibits glycogen synthase kinase-3beta: an investigation by docking simulation and experimental validation","volume":"584","author":"Mohammad","year":"2008","journal-title":"Eur. J. Pharm."},{"key":"10.1016\/j.psyneuen.2024.106987_bib35","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/npp.2012.112","article-title":"DNA methylation and its basic function","volume":"38","author":"Moore","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.psyneuen.2024.106987_bib36","first-page":"9","article-title":"Antipsychotic olanzapine-induced misfolding of proinsulin in the endoplasmic reticulum accounts for atypical development of diabetes","author":"Ninagawa","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.psyneuen.2024.106987_bib37","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1126\/science.1103160","article-title":"Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes","volume":"306","author":"Ozcan","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.psyneuen.2024.106987_bib38","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqad025","article-title":"Antipsychotic-induced alterations in lipid turnover","volume":"164","author":"Pereira","year":"2023","journal-title":"Endocrinology"},{"key":"10.1016\/j.psyneuen.2024.106987_bib39","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S2215-0366(19)30416-X","article-title":"Comparative effects of 18 antipsychotics on metabolic function in patients with schizophrenia, predictors of metabolic dysregulation, and association with psychopathology: a systematic review and network meta-analysis","volume":"7","author":"Pillinger","year":"2020","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.psyneuen.2024.106987_bib40","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1073\/pnas.1006875108","article-title":"Neural dysregulation of peripheral insulin action and blood pressure by brain endoplasmic reticulum stress","volume":"108","author":"Purkayastha","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.psyneuen.2024.106987_bib41","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21249362","article-title":"Understanding mechanisms underlying non-alcoholic fatty liver disease (NAFLD) in mental illness: risperidone and olanzapine alter the hepatic proteomic signature in mice","volume":"21","author":"Rostama","year":"2020","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.psyneuen.2024.106987_bib42","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.mce.2018.10.009","article-title":"Hsp90 inhibition in adrenocortical carcinoma: limited drug synergism with mitotane","volume":"480","author":"Sbiera","year":"2019","journal-title":"Mol. Cell Endocrinol."},{"issue":"Suppl 2","key":"10.1016\/j.psyneuen.2024.106987_bib43","doi-asserted-by":"crossref","first-page":"S115","DOI":"10.1016\/j.euroneuro.2007.02.003","article-title":"The stable patient with schizophrenia--from antipsychotic effectiveness to adherence","volume":"17","author":"Thomas","year":"2007","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.psyneuen.2024.106987_bib44","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.3892\/etm.2014.1580","article-title":"FIZZ1 promotes airway remodeling through the PI3K\/Akt signaling pathway in asthma","volume":"7","author":"Wang","year":"2014","journal-title":"Exp. Ther. Med"},{"key":"10.1016\/j.psyneuen.2024.106987_bib45","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/nrd2379","article-title":"Muscarinic acetylcholine receptors: mutant mice provide new insights for drug development","volume":"6","author":"Wess","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.psyneuen.2024.106987_bib46","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1007\/s40263-013-0115-5","article-title":"Second generation antipsychotic-induced type 2 diabetes: a role for the muscarinic M3 receptor","volume":"27","author":"Weston-Green","year":"2013","journal-title":"CNS Drugs"},{"key":"10.1016\/j.psyneuen.2024.106987_bib47","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.cmet.2023.11.009","article-title":"Central glucagon-like peptide 1 receptor activation inhibits Toll-like receptor agonist-induced inflammation","volume":"36","author":"Wong","year":"2024","journal-title":"Cell Metab"},{"key":"10.1016\/j.psyneuen.2024.106987_bib48","article-title":"An evaluation of the effects of the novel antipsychotic drug lurasidone on glucose tolerance and insulin resistance: a comparison with olanzapine","volume":"9","author":"Wu","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.psyneuen.2024.106987_bib49","doi-asserted-by":"crossref","first-page":"918","DOI":"10.2337\/db10-1433","article-title":"Sodium phenylbutyrate, a drug with known capacity to reduce endoplasmic reticulum stress, partially alleviates lipid-induced insulin resistance and beta-cell dysfunction in humans","volume":"60","author":"Xiao","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.psyneuen.2024.106987_bib50","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.cmet.2006.10.001","article-title":"GLP-1 receptor activation improves beta cell function and survival following induction of endoplasmic reticulum stress","volume":"4","author":"Yusta","year":"2006","journal-title":"Cell Metab."},{"key":"10.1016\/j.psyneuen.2024.106987_bib51","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/s41537-022-00276-2","article-title":"Antipsychotic-induced weight gain and metabolic effects show diurnal dependence and are reversible with time restricted feeding","volume":"8","author":"Zapata","year":"2022","journal-title":"Schizophrenia"},{"key":"10.1016\/j.psyneuen.2024.106987_bib52","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/nature07203","article-title":"From endoplasmic-reticulum stress to the inflammatory response","volume":"454","author":"Zhang","year":"2008","journal-title":"Nature"}],"container-title":["Psychoneuroendocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306453024000313?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306453024000313?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T17:21:13Z","timestamp":1759684873000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306453024000313"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":52,"alternative-id":["S0306453024000313"],"URL":"https:\/\/doi.org\/10.1016\/j.psyneuen.2024.106987","relation":{},"ISSN":["0306-4530"],"issn-type":[{"value":"0306-4530","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Olanzapine\u2019s effects on hypothalamic transcriptomics and kinase activity","name":"articletitle","label":"Article Title"},{"value":"Psychoneuroendocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psyneuen.2024.106987","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106987"}}